JASON LUDLOW: Open Payments
NPI 1952924938 · HILLSBORO, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 69 payments from 13 companies in 2025. Trend: 2023 $1,513 · 2024 $2,049 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $574 |
| Lilly USA, LLC | 9 | $261 |
| UCB, Inc. | 5 | $113 |
| Amgen Inc. | 4 | $89 |
| Incyte Corporation | 4 | $88 |
| GENZYME CORPORATION | 3 | $76 |
| PFIZER INC. | 3 | $63 |
| Organon LLC | 2 | $56 |
| Arcutis Biotherapeutics, Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
Products named: SKYRIZI, RINVOQ, TALTZ, Bimzelx, Otezla, OPZELURA, DUPIXENT, EBGLYSS.
Industry payments across OR — which companies pay providers there.
